(Q44594532)

4 December 2017

Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis (English)

1 reference

4 December 2017

Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis (English)

1 reference

13 March 2024

1 reference

1 reference

13 March 2024

7

Veli-Matti Kosma

1 reference

4 December 2017

Kirsi Voutilainen

1

1 reference

4 December 2017

Maarit Anttila

2

1 reference

4 December 2017

Sari Sillanpää

3

1 reference

4 December 2017

Raija Tammi

4

1 reference

4 December 2017

Markku Tammi

5

1 reference

4 December 2017

Seppo Saarikoski

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

10 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14506734

full work available at URL

13 March 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.11423

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506734

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.11423

13 March 2024

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.11423

13 March 2024

1 reference

International Journal of Cancer

13 March 2024

published in

1 reference

4 December 2017

107

1 reference

4 December 2017

359-364

1 reference

4 December 2017

3

1 reference

4 December 2017

Global cancer statistics

1 reference

The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary.

21 January 2018

1 reference

Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.

21 January 2018

1 reference

Distribution of the large aggregating proteoglycan versican in adult human tissues

21 January 2018

1 reference

Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma

21 January 2018

1 reference

Versican is differentially expressed in human melanoma and may play a role in tumor development.

21 January 2018

1 reference

Statistical aspects of prognostic factor studies in oncology

21 January 2018

1 reference

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

Hormone-regulated expression and localization of versican in the rodent ovary

21 January 2018

1 reference

Human granulation-tissue fibroblasts show enhanced proteoglycan gene expression and altered response to TGF-beta 1.

21 January 2018

1 reference

Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro

21 January 2018

1 reference

Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions

21 January 2018

1 reference

Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors

21 January 2018

1 reference

beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican

21 January 2018

1 reference

Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.

21 January 2018

1 reference

Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain.

21 January 2018

1 reference

The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs

21 January 2018

1 reference

Cell adhesion and proliferation mediated through the G1 domain of versican

21 January 2018

1 reference

Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells

21 January 2018

1 reference

Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas

21 January 2018

1 reference

Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin

21 January 2018

1 reference

Immunohistochemical localization of large chondroitin sulfate proteoglycan in odontogenic tumor

21 January 2018

1 reference

Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican

21 January 2018

1 reference

Differentiation of mesothelioma cells is influenced by the expression of proteoglycans

21 January 2018

1 reference

Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs

21 January 2018

1 reference

Domain organization, genomic structure, evolution, and regulation of expression of the aggrecan gene family

21 January 2018

3

1 reference

Multiple domains of the large fibroblast proteoglycan, versican

13 March 2024

4

1 reference

Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast

13 March 2024

15

1 reference

High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer

13 March 2024

18

1 reference

Hyaluronan metabolism in skin.

13 March 2024

19

1 reference

Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding.

13 March 2024

33

1 reference

13 March 2024

Identifiers

DOI

10.1002/IJC.11423

1 reference

4 December 2017

1 reference